United States · FDA National Drug Code directory
CHOLESTYRAMINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42806-267_f8db9100-22d4-4828-9e5b-b6e4e639de08
- Product NDC
- 42806-267
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- cholestyramine
- Labeler
- EPIC PHARMA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211215
- Source listing expiry
- 20261231
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/9g
These values do not establish equivalence or a dose recommendation.
Packages
- 378 g in 1 JAR (42806-267-93) · 42806-267-93
- 378 g in 1 CAN (42806-267-97) · 42806-267-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →